Patients with advanced chronic kidney disease (CKD) and at least moderate ischemia on stress testing showed high rates of both all-cause and cardiovascular mortality at 5-year follow-up of the randomized ISCHEMIA-CKD trial, while the trial’s initial comparative strategies – invasive vs. conservative – continued to show no significant difference in survival rates, new results show.